Clinical Trial Update: Long-term Study of Cariprazine in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Long-term Phase 3 study of cariprazine in schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2019-07-26